Mithra Biotechnology Inc.

Mithra's work centers on translating nonclinical data into rational study designs, including first-in-human dose considerations, PK/PD modeling, and bioanalytical strategy development. We also provide analytical characterization for protein therapeutics and maintain long-standing expertise in bioavailability and bioequivalence (BA/BE) studies, offering a broad scientific foundation across the development continuum. By applying fit-for-purpose methodologies aligned with international regulatory expectations, we aim to provide dependable data and thoughtful scientific support that help sponsors advance their programs with clarity and confidence.